Kyrgyzstan - Import of Heparin for Therapeutic Use
Since 2013, Kyrgyzstan Import of Heparin for Therapeutic Use decreased by 40.6% year on year. With $3,939 in 2018, the country was ranked number 124 comparing other countries in Import of Heparin for Therapeutic Use. Kyrgyzstan is overtaken by Gambia, which was ranked number 123 at $4,119.01 and is followed by Rwanda with $2,922. France topped the ranking with $960,128,653.6 in 2019, a fall of 6.6% versus 2018. United States, Singapore and Germany respectively ranked number 2, 3 and 4 in this ranking. Belize witnessed the best average annual growth at +183.7% per year, while Mauritania recorded the worst performance at -81.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2018 | 3,939.00 |
| 2017 | 2,598.00 |
| 2016 | 2,099.00 |
| 2015 | 4,132.00 |
| 2014 | 41,212.00 |
Download all data from 2000 to 2018
How does Kyrgyzstan rank in Import of Heparin for Therapeutic Use?
| # | 152 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
France
|
960,128,653.60 | 2019 | -6.6 % | -5.3 % | View data | |
| 2 |
#2
United States
|
422,842,642.50 | 2019 | +0.9 % | +2.3 % | View data | |
| 123 |
#123
Gambia
|
4,119.01 | 2015 | NA | NA | View data | |
| 124 |
#124
Kyrgyzstan
|
3,939.00 | 2018 | +51.6 % | -40.5 % | View data | |
| 125 |
#125
Rwanda
|
2,922.00 | 2019 | -14.6 % | +45.9 % | View data | |